EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The diagnostic accuracy of 68 Ga‐PSMA‐PET/CT in primary staging of patients with high‐risk nonmetastatic prostate cancer treated with radical prostatectomy: A single‐center cohort analysis

Pawel Rajwa iD, Julian Heidenreich, Alexander Drzezga, Matthias Schmidt, Shahrokh F Shariat, Axel Heidenreich

The Prostate · 2024

DOI: 10.1002/pros.24627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Pawel Rajwa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

68 Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is a recommended imaging modality for patients with recurrent prostate cancer (PCa). Its routine implementation before radical prostatectomy (RP) may allow avoiding undertreatment. We aimed to analyze the diagnostic accuracy of 68 Ga‐PSMA‐PET/CT for pelvic lymph node metastases in a large cohort of patients treated with RP and extended pelvic lymph node dissection (ePLND) for high‐risk PCa.

Methods

This is a retrospective analysis of an institutional database of patients who underwent 68 Ga‐PSMA‐PET/CT before RP and ePLND for high‐risk PCa. The diagnostic estimates of 68 Ga‐PSMA‐PET/CT with 95% confidence intervals (CIs) for lymph node involvement were calculated.

Results

We included 165 high‐risk PCa patients. The median PSA value was 24.5 ng/mL (range: 6.7–185) and all the patients had biopsy Grade Group 4–5. In total, 46 (28%) of patients had clinical lymph node involvement at 68 Ga‐PSMA‐PET/CT. A mean number of resected lymph nodes per patient was 22 (range: 15–45) and 149 (4.2%) of all resected nodes were positive for lymph node metastasis at final pathology. The diagnostic estimates for the detection of pN+ disease at RP were as follows: sensitivity 63% (95% CI: 51–75), specificity 97% (95% CI: 91–99), positive predictive value 94% (95% CI: 82–99), and negative predictive value 79% (95% CI: 70–86). The total accuracy of PSMA‐PET was 83% (95% CI: 76–88).

Conclusion

Our analyses support high specificity and positive predictive value of pretreatment 68 Ga‐PSMA PET/CT for the detection of pelvic lymph node metastasis in patients treated with RP for high‐risk PCa. While a positive finding should be considered as robust indicator for clinical decision‐making, a negative result cannot reliably rule out the presence of lymph node involvement in high‐risk PCa; there is a need for advanced risk stratification in those patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsMaleHumansProstateLymphatic MetastasisRetrospective StudiesNeoplasm Recurrence, LocalProstatectomyGallium RadioisotopesNeoplasm Staging

Stichwörter der Autor:innen

PSMA PETlymph node dissectionnonmetastaticprostate cancerradical prostatectomy

Substanzen

Gallium Radioisotopes

Autor:innen und Institutionen

  • Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany.
  • Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
  • Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.

ORCID-Profile: Pawel Rajwa

Zitieren

APA

Rajwa, P., Heidenreich, J., Drzezga, A., Schmidt, M., Shariat, S. F., & Heidenreich, A. (2024). The diagnostic accuracy of 68 Ga‐PSMA‐PET/CT in primary staging of patients with high‐risk nonmetastatic prostate cancer treated with radical prostatectomy: A single‐center cohort analysis. The Prostate. https://doi.org/10.1002/pros.24627

Vancouver

Rajwa P, Heidenreich J, Drzezga A, Schmidt M, Shariat SF, Heidenreich A. The diagnostic accuracy of 68 Ga‐PSMA‐PET/CT in primary staging of patients with high‐risk nonmetastatic prostate cancer treated with radical prostatectomy: A single‐center cohort analysis. The Prostate. 2024. doi:10.1002/pros.24627

BibTeX
@article{Rajwa2024,
  author = {Rajwa, Pawel and Heidenreich, Julian and Drzezga, Alexander and Schmidt, Matthias and Shariat, Shahrokh F and Heidenreich, Axel},
  title = {The diagnostic accuracy of 68 Ga‐PSMA‐PET/CT in primary staging of patients with high‐risk nonmetastatic prostate cancer treated with radical prostatectomy: A single‐center cohort analysis},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24627}
}
Kostenlos starten →